Hermetica Superfood Encyclopedia
The Short Answer
Apocynin is a naturally occurring acetophenone derived primarily from the roots of Picrorhiza kurroa that functions as a selective NADPH oxidase (NOX2) inhibitor. It reduces superoxide radical production at the cellular level, making it a studied candidate for oxidative stress-related conditions including respiratory and cardiovascular disease.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordapocynin benefits
Synergy Pairings3
Apocynin — botanical close-up
Health Benefits
Origin & History
Natural habitat
Apocynin is a natural polyphenolic compound first isolated in 1908 from the roots of Apocynum cannabinum (Canadian hemp) and later from Picrorhiza kurroa, a Himalayan medicinal plant. It is extracted using solvent-based methods from plant roots, with commercial preparations typically containing >98% pure apocynin powder.
“Apocynin's source plants have extensive traditional use - Apocynum cannabinum was used by Native American tribes (Ojibwe, Iroquois) for edema and heart conditions, while Picrorhiza kurroa has been used in Ayurveda for approximately 2,000 years for liver disorders and asthma. The compound was first pharmacologically noted in 1883 by Oswald Schmiedeberg.”Traditional Medicine
Scientific Research
Human clinical evidence for apocynin is extremely limited, with only small pilot studies available. A crossover RCT (n=24) found NADPH oxidase inhibition in leukocytes but no systemic anti-inflammatory effects (PMID: 15826943), while trials in cystic fibrosis (PMID: 22362838) and Parkinson's disease (PMID: 23562035) showed minimal clinical benefit.
Preparation & Dosage
Traditional preparation
Clinically studied doses include: Oral - 20-30 mg daily as pure powder (>98% purity); Inhaled - 10-50 mg nebulized solution for respiratory conditions. No standardized extracts are established, and human safety data are limited to these low doses in short-term studies. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Apocynin (4'-hydroxy-3'-methoxyacetophenone) is a purified phenolic compound, not a food ingredient, so conventional macronutrient/micronutrient framing does not apply. Molecular weight: 166.17 g/mol. Chemical formula: C9H10O3. It is a methoxy-substituted catechol structurally related to acetovanillone, isolated primarily from the root of Picrorhiza kurroa (also found in Apocynum cannabinum). As a purified compound used in research and supplement contexts, it contains no meaningful protein, fat, carbohydrate, fiber, vitamins, or dietary minerals. Bioactive concentration in typical experimental dosing: 1–10 mM in cell studies; oral doses in preclinical animal models range from 0.5–100 mg/kg body weight. One human pilot study used inhaled apocynin at 3 mg/kg. Oral bioavailability in humans is not well-characterized; animal data suggest it undergoes hepatic first-pass metabolism and requires oxidative dimerization (forming diapocynin) to exert full NOX2-inhibitory activity — meaning bioavailability of the active form depends on cellular redox environment. Partition coefficient (LogP): approximately 0.72, suggesting moderate lipophilicity. Half-life data in humans is not established; rodent pharmacokinetic studies indicate rapid distribution and metabolism within 1–4 hours post-oral administration.
How It Works
Mechanism of Action
Apocynin inhibits the assembly of the NADPH oxidase (NOX2) complex by blocking the translocation of the cytosolic subunit p47-phox to the membrane, thereby reducing superoxide anion (O2−) generation. This suppression of reactive oxygen species (ROS) secondarily dampens NF-κB transcription factor activation, lowering downstream pro-inflammatory cytokine expression including TNF-α and IL-6. Apocynin may also act as a direct free radical scavenger after enzymatic oxidation to diapocynin, its active dimer form.
Clinical Evidence
Most evidence for apocynin derives from in vitro cell studies and animal models, where it consistently reduces NOX2-derived superoxide and inflammatory markers. One small pilot study in cystic fibrosis patients explored inhaled apocynin for airway oxidative stress, but sample sizes were insufficient to establish efficacy. A limited number of human pharmacokinetic studies confirm oral bioavailability and conversion to diapocynin, though no large randomized controlled trials have established clinical endpoints. Overall, the evidence base remains preclinical, and human therapeutic claims are not yet substantiated.
Safety & Interactions
Apocynin is generally considered low-toxicity at doses studied in animals, but comprehensive human safety data are lacking due to the absence of large clinical trials. Because it inhibits NADPH oxidase and suppresses ROS, it may theoretically blunt beneficial immune responses, particularly bactericidal activity of neutrophils, raising concern in immunocompromised individuals. Apocynin may interact additively with anticoagulants such as warfarin or antiplatelet drugs, as it shares structural similarity with acetophenone derivatives that can affect platelet function. Pregnant or breastfeeding women should avoid apocynin due to the complete absence of reproductive safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
4-hydroxy-3-methoxyacetophenoneAcetovanilloneCanadian hemp extractPicrorhiza extractVanillic acetone4'-hydroxy-3'-methoxyacetophenoneKatuki extractKutki extract
Frequently Asked Questions
What is apocynin and where does it come from?
Apocynin (4-hydroxy-3-methoxyacetophenone) is a phenolic compound found naturally in the roots of Picrorhiza kurroa, a plant used in Ayurvedic medicine, as well as in smaller amounts in other plants such as Apocynum cannabinum. It was first isolated in the 19th century and has since been studied primarily for its ability to inhibit the NOX2 enzyme complex.
How does apocynin reduce inflammation?
Apocynin reduces inflammation by blocking the assembly of the NADPH oxidase (NOX2) complex, specifically preventing the p47-phox subunit from docking at the membrane, which cuts superoxide (O2−) production. Lower ROS levels reduce activation of the NF-κB signaling pathway, leading to decreased transcription of pro-inflammatory mediators such as TNF-α, IL-1β, and IL-6. This dual antioxidant and anti-inflammatory action has been consistently demonstrated in animal models of arthritis, neuroinflammation, and pulmonary inflammation.
What is the studied dosage of apocynin in humans?
Human dosage data for apocynin are very limited. The cystic fibrosis pilot trial used inhaled apocynin at doses in the range of 3–9 mg per inhalation session, while animal studies typically use oral doses of 5–100 mg/kg body weight. No standardized oral supplement dose has been established or validated through phase II or III clinical trials, making it premature to recommend a specific human dosage.
Can apocynin help with cystic fibrosis?
Apocynin has been investigated as an inhaled therapy for cystic fibrosis because NADPH oxidase-derived oxidative stress contributes significantly to airway inflammation in CF patients. A small exploratory study showed some reduction in airway oxidative markers following inhaled apocynin, but the trial was underpowered and did not measure clinical lung function endpoints such as FEV1. More robust randomized controlled trials are needed before apocynin can be recommended as a CF treatment.
Does apocynin interact with any medications?
Apocynin may interact with anticoagulant medications such as warfarin or antiplatelet agents like aspirin and clopidogrel, as its phenolic structure and antioxidant activity can influence platelet aggregation and coagulation pathways. It may also have additive effects with other antioxidant or anti-inflammatory supplements, potentially over-suppressing immune-mediated ROS production needed for pathogen clearance. Patients taking immunosuppressants, blood thinners, or antihypertensives should consult a physician before using apocynin, as formal drug-interaction studies in humans have not been conducted.
What does the current clinical evidence show about apocynin's effectiveness?
Most evidence for apocynin comes from laboratory and animal studies demonstrating its ability to inhibit NADPH oxidase and reduce oxidative stress. Human clinical trials are limited; the strongest human data is a small pilot study (n=6) in cystic fibrosis patients showing modest reductions in sputum inflammatory markers but no measurable improvements in lung function. Large-scale randomized controlled trials in humans are needed to establish efficacy and safety in clinical populations.
Who should consider taking apocynin supplements and who should avoid it?
Apocynin may be of interest to individuals with inflammatory conditions or those seeking antioxidant support, though evidence in humans remains preliminary. Pregnant and nursing women should avoid apocynin due to insufficient safety data, and individuals with existing respiratory conditions should consult a healthcare provider before use. Children and the elderly should also seek medical guidance, as age-specific safety and dosing studies have not been conducted.
How does apocynin compare to other natural antioxidants for reducing oxidative stress?
Apocynin operates through a specific mechanism—inhibiting the NOX2 enzyme of NADPH oxidase—which differs from broad-spectrum antioxidants like vitamins C and E that neutralize free radicals directly. While this targeted mechanism is theoretically advantageous for conditions involving NOX-derived reactive oxygen species, direct comparative human studies between apocynin and other antioxidants have not been conducted. Most evidence supporting apocynin's oxidative stress reduction comes from cellular and animal models rather than head-to-head human trials.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w apocynin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
